Adaptive Biotechnologies (NASDAQ:ADPT) used a presentation at the J.P. Morgan healthcare conference to outline growth drivers for its clonoSEQ minimal residual disease (MRD) franchise and to describe ...
The property is being pitched for its flexibility, with options for a buyer to hold it as offices, redevelop the site, or ...
This Asus 24″ 1080p Eye Care monitor features a 23.8-inch Full HD IPS screen with thin bezels, a 100 Hz refresh rate, and a ...
8h
Human Touch® Introduces the Super Novo 3.0: The Next Advancement in Intelligent Wellness at CES 2026
Debuting at Booth #14726, Central Hall LAS VEGAS, NV, UNITED STATES, January 6, 2026 /EINPresswire.com/ — Human Touch®, the ...
Sexual behaviour among same-sex pairs is common in apes and monkeys, and a wide-ranging analysis suggests it does boost survival ...
A new adaptive metaskin hides objects from thermal cameras in both hot and cold environments, automatically adjusting its ...
This article is part of Kotaku Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. The Google Pixel 9a Android smartphone features a 6.
Is the 2025 F-150 losing its edge? One owner’s new Lariat is “chugging” and hesitating at just 3K miles. "My 2015 never felt ...
Shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) surged around 16% in premarket trading on Monday after the ...
To govern AI safely and keep its speed advantage, enterprises must move from static, rule-based control systems to adaptive, ...
Adaptive Biotechnologies plans to release its complete fourth quarter and full year 2025 financial results during its earnings call in February 2026. 1 Excludes Digital Biotechnologies, Inc. cash and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback